1 - Has the last order of 25K tests been sold yet -  I remember there was talk that the next order would be for 50K tests.  How close to placing that order are we, and once it is made, will there be talk of expanding on the quantity for a subsequent order?  100k?

2 - Are you able to quantify what kind of level your team is working on psilocybin research right now?  It's clearly and understandably not a priority right now, but do you have a team of ANY size currently working on research to get ahead of the game?

3 - Update on short-interest or short attacks.  Are we in the same situation we were a number of weeks ago, or have we beaten through the worst of that?